Basic Information
PONTALON CAPSULE 250 mg
CAPSULE
Regulatory Information
SIN08483P
December 16, 1995
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XM01AG01
Company Information
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Active Ingredients
MEFENAMIC ACID
Strength: 250 mg
Detailed Information
Contraindications
**Contraindication(s):** 1. Pontalon should not be used in patients who have previously exhibited hypersensitivity to it. 2. Pontalon is contraindicated in patients with active ulceration or chronic inflammation of either the upper or lower gastrointestinal tract. 3. Pontalon should be avoided in patients with pre-existing renal disease.
Indication Information
**Indication(s):** For the relief of mild to moderate pain including muscular, traumatic and dental pain, headache, postoperative and postpartum pain, and dysmenorrhea.